---
document_datetime: 2023-09-21 19:01:37
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/steps-after-cutoff/novoseven-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
document_name: novoseven-epar-steps-taken-after-authorisation-when-cutoff-date-has-been-used_en.pdf
version: success
processing_time: 1.9900305
conversion_datetime: 2025-12-14 13:24:33.972697
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
## Procedural steps taken after granting the Marketing Authorisation

## For procedures finalised after 1 February 2004 please refer to module 8B.

- The changes introduced in the revision 1 of this EPAR are editorial amendments to Part III, section 4: Overview of part IV of the dossier: clinical aspects.
- The MAH submitted on 26 March 1997 an application for a Type II variation, in order to apply for  the  use  of  NovoSeven  also  outside  of  specialized  centres,  pursuant  to  Article  6  of Commission Regulation (EC) No 542/95 of 10 March 1995. The procedure started on 18 April 1997,  supplementary  information  was  supplied  by  the  MAH  on  1  July  1997  and  a  positive opinion  was  adopted  by  the  CPMP  on  23  July  1997 . The  European  Commission  granted  a Commission decision on 4 December 1997.
- The MAH submitted on 23 July 1997, three applications for three Type I variations No 12 of Annex I, (type II procedure applicable) in order to apply for a change in the manufacture of the bulk  product,  pursuant  to  Article  4  of  Commission  Regulation  (EC)  No  542/95  of  10  March 1995 as amended. The procedures started on 25 July 1997 and a positive opinion was adopted by the CPMP on 24 September 1997.
- The MAH submitted on 16 April 1998, an application for a Type I variation No 12 of Annex I, (type  II  procedure  applicable)  in  order  to  remove  the  bovine  derived  Primatone  RL  from the cultivation process in order to minimise the use of animal derived material, pursuant to Article 4 of  Commission  Regulation  (EC)  No  542/95  of  10  March  1995  as  amended.  The  procedure started on 24 April 1998 and a positive opinion was adopted by the CPMP on 24 June 1998.
- The MAH submitted on 16 April 1998 an application for a Type II variation, in order to apply for an additional needle for injection, pursuant to Article 6 of Commission Regulation (EC) No 542/95 of 10 March 1995 as amended. The procedure started on 24 April 1998, supplementary information was supplied by the MAH on 10 July 1998 and a positive opinion was adopted by the CPMP on 23 July 1998. The European Commission granted a Commission decision on 19 November 1998.
- The MAH submitted on 6 April 1998, an application for a Notification of a Type I variation No 20 of Annex I, in order to change the shelf-life of the finished product, pursuant to Article 4 of Commission Regulation (EC) No 542/95 of 10 March 1995 as amended. The procedure started on 16 April 1998 and a positive opinion was adopted by the CPMP on 15 May 1998.
- The  MAH submitted on 30 October  1998 an  application  for  a  Type  II  variation,  in  order  to apply for the extension of the storage period/shelf life of bulk product, pursuant to Article 6 of Commission Regulation (EC) No 542/95 of 10 March 1995 as amended. The procedure started on 20 November 1998 and a positive opinion was adopted by the CPMP on 27 January 1999 .
- The  MAH submitted on 30 October  1998 an  application  for  a  Type  II  variation,  in  order  to apply  for  changes  in  the  bulk  product  specification,  pursuant  to  Article  6  of  Commission Regulation  (EC)  No  542/95  of  10  March  1995  as  amended.  The  procedure  started  on  20 November 1998 and a positive opinion was adopted by the CPMP on 27 January 1999 .
- The  MAH submitted on 30 October  1998 an  application  for  a  Type  II  variation,  in  order  to apply  for  the  replacement  of  the  test  for  pyrogens,  pursuant  to  Article  6  of  Commission Regulation  (EC)  No  542/95  of  10  March  1995  as  amended.  The  procedure  started  on  20 November 1998 and a positive opinion was adopted by the CPMP on 27 January 1999 .
- The MAH submitted on 30 October 1998, an application for a Type I variation No 12 of Annex I,  (type  II  procedure  applicable)  in  order  to  apply  for  minor  changes  to  the  manufacturing

<div style=\"page-break-after: always\"></div>

process  related  to  the  fermentation  and  purification  processes,  pursuant  to  Article  4  of Commission Regulation (EC) No 542/95 of 10 March 1995 as amended. The procedure started on 18 December 1998 and a positive opinion was adopted by the CPMP on 23 February 1999.

- The MAH submitted on 30 October 1998, an application for a Type I variation No 11 of Annex I,  (type  II  procedure  applicable)  for  the  addition  of  an  alternative  manufacturer  of  the  raw material, pursuant to Article 4 of Commission Regulation (EC) No 542/95 of 10 March 1995 as amended. The procedure started on 18 December 1998 and a positive opinion was adopted by the CPMP on 23 February 1999.
- The MAH submitted on 19 May 1999 an application for a Type II variation at the request of the CPMP following the the evaluation of the 4 th and  5 th PSUR, in order to modify the SPC and Package Leaflet, pursuant to Article 6 of Commission Regulation (EC) No 542/95 of 10 March 1995  as  amended.  The  procedure  started  on  21  May  1999,  supplementary  information  was supplied by the MAH on 30 June 1999 and a positive opinion was adopted by the CPMP on 28 July 1999 . The European Commission granted a Commission decision on 8 December 1999.

Subsequent post Marketing Authorisation applications agreed upon are summarised in the table below:

| Scope                                                                                               | Application number   | Type of modification 1   | Notification/ Opinion issued on 2   | Commission Decision Issued/amen ded on   |
|-----------------------------------------------------------------------------------------------------|----------------------|--------------------------|-------------------------------------|------------------------------------------|
| Quality changes                                                                                     | II/15                | II                       | 19.10.00                            | 28.11.00                                 |
| Replacement of an excipient with a comparable excipient                                             | I/16                 | I                        | 15.09.00                            | 12.10.00                                 |
| Renewal                                                                                             | R/17                 | R                        | 25/01.01                            | 3.05.01                                  |
| Update of summary of product characteristics and package leaflet                                    | II/18                | II                       | 01.03.01                            | 20.06.01                                 |
| Changes to comply with supplements to pharmacopoeias                                                | I/19                 | I                        | 13.03.01                            | 06.04.01                                 |
| Minor change of manufacturing process of the active substance                                       | I/20                 | I                        | 25.04.02                            | 29.04.02                                 |
| Minor change of manufacturing process of the active substance                                       | I/21                 | I                        | 25.04.02                            | 29.04.02                                 |
| Synthesis or recovery of non-pharmacopoeial excipients in the medicinal products                    | I/22                 | I                        | 15.07.02                            | 15.07.02                                 |
| Change in test procedure of active substance and Change in test procedures of the medicinal product | I/23                 | I                        | 21.11.02                            | 09.12.02                                 |
| Change in the batch size of finished product                                                        | I/24                 | I                        | 20.02.03                            | 10.03.03                                 |
| Minor changes in manufacture of the medicinal product                                               | I/25                 | I                        | 20.02.03                            | 10.03.03                                 |
| Change(s) to shelf-life or storage conditions                                                       | II/27                | II                       | 24.07.03                            | 08.10.03                                 |
| Extension of Indication                                                                             | II/28                | II                       | 22.10.03                            | 27.01.04                                 |
| Extension of Indication                                                                             | II/29                | II                       | 22.10.03                            | 27.01.04                                 |
| Update of Summary of Product Characteristics and Package Leaflet                                    | II/30                | II                       | 25.09.03                            | 27.01.04                                 |
| Update of Summary of Product Characteristics and Package Leaflet                                    | II/31                | II                       | 25.09.03                            | 27.01.04                                 |
| Change in test procedure of active substance                                                        | I/32                 | I                        | 22.08.03                            | 22.09.03                                 |

1 In accordance with Commission Regulation (EC) No. 542/95 of 10 March 1995, as amended: I refers to a minor variation (Type I variation); II refers to a major variation (Type II variation); I/II refers to a minor variation following the procedure set out in Article 6, 7 and 8 of the Regulation; X refers to an Annex II application.

T refers to a transfer of a Marketing Authorisation in accordance with Commission Regulation (EC) No 2141/96 of 7 November 1996.

N refers to a notification in accordance with Article 10(3) of Council Directive 92/27/EEC of 31 March 1992.

2 For Notifications and Type I variations, the date of entry into force of the change is the EMEA Notification date. The Commission Decision will be amended accordingly.